Skip to main navigation Skip to search Skip to main content

Evidence of depression-associated circadian rhythym disruption and regret in prostate cancer patients after surgery

Joanne Christie, Christopher Sharpley, Vicki Bitsika, David Christie

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)

Abstract

Purpose The purpose of this study is to investigate the association between prostate cancer (PCa) patients' regret that their surgery harmed them, and their scores on the two key symptoms of major depressive disorder (depressed mood, anhedonia) and a symptom of melancholic depression (disruption to circadian rhythm). Methods Forty PCa patients who had received surgery for their PCa completed a postal survey including background information, regret about surgery that 'did them a lot of harm' and three items drawn from the Zung Self-Rating Depression Scale measuring depressed mood, anhedonia and circadian rhythm disruption. Results There were significant correlations between all three symptoms of depression (depressed mood, anhedonia, disruption to circadian rhythm) and between patients' regret that surgery did them a lot of harm and their circadian rhythm disruption, but not between depressed mood or anhedonia and regret about surgery doing harm. Conclusions These findings suggest that PCa patients' postsurgery regrets about major harm may lead to a significant disruption in a central physiological function and raise the need to consider this side effect of surgery when planning supportive services for these men.
Original languageEnglish
Pages (from-to)3603-3605
JournalSupportive Care in Cancer
Volume25
Issue number12
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Central Nervous System

Fingerprint

Dive into the research topics of 'Evidence of depression-associated circadian rhythym disruption and regret in prostate cancer patients after surgery'. Together they form a unique fingerprint.

Cite this